Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).



Status:Recruiting
Conditions:Psoriasis, Dermatology, Dermatology, Dermatology
Therapuetic Areas:Dermatology / Plastic Surgery
Healthy:No
Age Range:12 - 17
Updated:3/30/2019
Start Date:June 19, 2018
End Date:June 18, 2020
Contact:LEO Pharma A/S
Email:disclosure@leo-pharma.com
Phone:(+1) 877-557-1168

Use our guide to learn which trials are right for you!

A Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Trial to Evaluate the Efficacy, Safety, and Tolerability of Tralokinumab Monotherapy in Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD) Who Are Candidates for Systemic Therapy

Primary objective:

To evaluate the efficacy of subcutaneous (SC) administration of tralokinumab compared with
placebo in treating adolescent subjects (age 12 to <18 years) with moderate-to-severe AD.

Secondary objectives:

To evaluate the efficacy of tralokinumab on severity and extent of AD, itch, and
health-related quality of life compared with placebo.

To investigate the safety, immunogenicity, and tolerability of SC administration of
tralokinumab compared with placebo when used to treat adolescent subjects (age 12 to <18
years) with moderate-to-severe AD.


Inclusion Criteria:

- Age 12 to 17.

- Diagnosis of AD as defined by the Hanifin and Rajka (1980) criteria for AD.

- History of AD for ≥1 year.

- History of topical corticosteroid (TCS; Europe: Class 3 or higher; US: Class 4 or
lower) and/or topical calcineurin inhibitor (TCI) treatment failure or subjects for
whom these topical AD treatments are medically inadvisable.

- AD involvement of ≥10% body surface area at screening and baseline.

- Stable dose of emollient twice daily (or more, as needed) for at least 14 days before
randomisation.

Exclusion Criteria:

- Active dermatologic conditions that may confound the diagnosis of AD.

- Use of tanning beds or phototherapy within 6 weeks prior to randomisation.

- Treatment with systemic immunosuppressive/immunomodulating drugs and/or systemic
corticosteroid within 4 weeks prior to randomisation.

- Treatment with TCS, TCI, or topical phosphodiesterase 4 (PDE-4) inhibitor within 2
weeks prior to randomisation.

- Receipt of any marketed biological therapy (i.e. immunoglobulin, anti immunoglobulin
E) including dupilumab or investigational biologic agents.

- Active skin infection within 1 week prior to randomisation.

- Clinically significant infection within 4 weeks prior to randomisation.

- A helminth parasitic infection within 6 months prior to the date informed consent is
obtained.

- Tuberculosis requiring treatment within the 12 months prior to screening.

- Known primary immunodeficiency disorder.
We found this trial at
33
sites
Los Angeles, California 90025
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Albany, Georgia 31707
?
mi
from
Albany, GA
Click here to add this to my saved trials
Ann Arbor, Michigan 48103
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Aurora, Colorado 80045
?
mi
from
Aurora, CO
Click here to add this to my saved trials
Austin, Texas 78759
?
mi
from
Austin, TX
Click here to add this to my saved trials
Baton Rouge, Louisiana 70808
?
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Bexley, Ohio 43209
?
mi
from
Bexley, OH
Click here to add this to my saved trials
Birmingham, Alabama 35209
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
Chicago, Illinois 60611
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Corning, New York 14830
?
mi
from
Corning, NY
Click here to add this to my saved trials
Darlinghurst, 95209
?
mi
from
Darlinghurst,
Click here to add this to my saved trials
Denver, Colorado 80206
?
mi
from
Denver, CO
Click here to add this to my saved trials
East Windsor, New Jersey 08520
?
mi
from
East Windsor, NJ
Click here to add this to my saved trials
Evansville, Tennessee 47713
?
mi
from
Evansville, TN
Click here to add this to my saved trials
Fort Smith, Arkansas 72916
?
mi
from
Fort Smith, AR
Click here to add this to my saved trials
Fountain Valley, California 92708
?
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
High Point, North Carolina 27262
?
mi
from
High Point, NC
Click here to add this to my saved trials
Houston, Texas 77065
?
mi
from
Houston, TX
Click here to add this to my saved trials
Louisville, Kentucky 40217
?
mi
from
Louisville, KY
Click here to add this to my saved trials
Miami, Florida 33144
?
mi
from
Miami, FL
Click here to add this to my saved trials
Minneapolis, Minnesota 55402
?
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Murfreesboro, Tennessee 37130
?
mi
from
Murfreesboro, TN
Click here to add this to my saved trials
New Haven, Connecticut 06520
?
mi
from
New Haven, CT
Click here to add this to my saved trials
New York, New York 10021
?
mi
from
New York, NY
Click here to add this to my saved trials
North Charleston, South Carolina 29420
?
mi
from
North Charleston, SC
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19104
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Portland, Oregon 97210
?
mi
from
Portland, OR
Click here to add this to my saved trials
San Antonio, Texas 78229
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
San Francisco, California 94132
?
mi
from
San Francisco, CA
Click here to add this to my saved trials
Stanford, California 94304
?
mi
from
Stanford, CA
Click here to add this to my saved trials
Stony Brook, New York 11790
?
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Tulsa, Oklahoma 74136
?
mi
from
Tulsa, OK
Click here to add this to my saved trials
Ypsilanti, Michigan 48197
?
mi
from
Ypsilanti, MI
Click here to add this to my saved trials